|
1
|
Shevra CR, Ghosh A and Kumar M: Cyclin D1
and Ki-67 expression in normal, hyperplastic and neoplastic
endometrium. J Postgrad Med. 61:15–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llauradó M, Ruiz A, Majem B, Ertekin T,
Colás E, Pedrola N, Devis L, Rigau M, Sequeiros T, Montes M, et al:
Molecular bases of endometrial cancer: New roles for new actors in
the diagnosis and the therapy of the disease. Mol Cell Endocrinol.
358:244–255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shibahara K, Asano M, Ishida Y, Aoki T,
Koike T and Honjo T: Isolation of a novel mouse gene MA-3 that is
induced upon programmed cell death. Gene. 166:297–301. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jansen AP, Camalier CE and Colburn NH:
Epidermal expression of the translation inhibitor programmed cell
death 4 suppresses tumorigenesis. Cancer Res. 65:6034–6041. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Allgayer H: Pdcd4, a colon cancer
prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol.
73:185–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bitomsky N, Böhm M and Klempnauer KH:
Transformation suppressor protein Pdcd4 interferes with
JNK-mediated phosphorylation of c-Jun and recruitment of the
coactivator p300 by c-Jun. Oncogene. 23:7484–7493. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leupold JH, Yang HS, Colburn NH, Asangani
I, Post S and Allgayer H: Tumor suppressor Pdcd4 inhibits
invasion/intravasation and regulates urokinase receptor (u-PAR)
gene expression via Sp-transcription factors. Oncogene.
26:4550–4562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wedeken L, Singh P and Klempnauer KH:
Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA. J
Biol Chem. 286:42855–42862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang HS, Jansen AP, Komar AA, Zheng X,
Merrick WC, Costes S, Lockett SJ, Sonenberg N and Colburn NH: The
transformation suppressor Pdcd4 is a novel eukaryotic translation
initiation factor 4A binding protein that inhibits translation. Mol
Cell Biol. 23:26–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fehler O, Singh P, Haas A, Ulrich D,
Müller JP, Ohnheiser J and Klempnauer KH: An evolutionarily
conserved interaction of tumor suppressor protein Pdcd4 with the
poly(A)-binding protein contributes to translation suppression by
Pdcd4. Nucleic Acids Res. 42:11107–11118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H, Ozaki I, Mizuta T, Hamajima H,
Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K and Matsuhashi S:
Involvement of programmed cell death 4 in transforming growth
factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Oncogene. 25:6101–6112. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Xin S, Yang D, Li X, He Z, Che X,
Wang J, Chen F, Wang X and Song X: Down-regulation of PDCD4
expression is an independent predictor of poor prognosis in human
renal cell carcinoma patients. J Cancer Res Clin Oncol.
138:529–535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao F, Wang X, Zhu F, Wang Q, Zhang X, Guo
C, Zhou C, Ma C, Sun W, Zhang Y, et al: PDCD4 gene silencing in
gliomas is associated with 5′CpG island methylation and
unfavourable prognosis. J Cell Mol Med. 13:4257–4267. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Y, Knösel T, Kristiansen G, Pietas A,
Garber ME, Matsuhashi S, Ozaki I and Petersen I: Loss of PDCD4
expression in human lung cancer correlates with tumour progression
and prognosis. J Pathol. 200:640–646. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mudduluru G, Medved F, Grobholz R, Jost C,
Gruber A, Leupold JH, Post S, Jansen A, Colburn NH and Allgayer H:
Loss of programmed cell death 4 expression marks adenoma-carcinoma
transition, correlates inversely with phosphorylated protein kinase
B, and is an independent prognostic factor in resected colorectal
cancer. Cancer. 110:1697–1707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Afonja O, Juste D, Das S, Matsuhashi S and
Samuels HH: Induction of PDCD4 tumor suppressor gene expression by
RAR agonists, antiestrogen and HER-2/neu antagonist in breast
cancer cells. Evidence for a role in apoptosis. Oncogene.
23:8135–8145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei ZT, Zhang X, Wang XY, Gao F, Zhou CJ,
Zhu FL, Wang Q, Gao Q, Ma CH, Sun WS, et al: PDCD4 inhibits the
malignant phenotype of ovarian cancer cells. Cancer Sci.
100:1408–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang T, Qiu H, Bao W, Li B, Lu C, Du G,
Luo X, Wang L and Wan X: Epigenetic inactivation of EFEMP1 is
associated with tumor suppressive function in endometrial
carcinoma. PLoS One. 8:e674582013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Walentowicz-Sadlecka M, Sadlecki P, Bodnar
M, Marszalek A, Walentowicz P, Sokup A, Wilińska-Jankowska A and
Grabiec M: Stromal derived factor-1 (SDF-1) and its receptors CXCR4
and CXCR7 in endometrial cancer patients. PLoS One. 9:e846292014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jeon YT, Park IA, Kim YB, Kim JW, Park NH,
Kang SB, Lee HP and Song YS: Steroid receptor expressions in
endometrial cancer: Clinical significance and epidemiological
implication. Cancer Lett. 239:198–204. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI
|
|
24
|
Zhang H, Li M, Zheng X, Sun Y, Wen Z and
Zhao X: Endometriotic stromal cells lose the ability to regulate
cell-survival signaling in endometrial epithelial cells in vitro.
Mol Hum Reprod. 15:653–663. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang KH, Miller N, Kheirelseid EA,
Ingoldsby H, Hennessy E, Curran CE, Curran S, Smith MJ, Regan M,
McAnena OJ and Kerin MJ: MicroRNA-21 and PDCD4 expression in
colorectal cancer. Eur J Surg Oncol. 37:597–603. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu W, Gao T, Shen J, Sun Y, Zheng X, Wang
J, Ma J, Hu XY, Li J and Hu MJ: MicroRNA-183 inhibits apoptosis and
promotes proliferation and invasion of gastric cancer cells by
targeting PDCD4. Int J Clin Exp Med. 7:2519–2529. 2014.PubMed/NCBI
|
|
27
|
Gao F, Zhang P, Zhou C, Li J, Wang Q, Zhu
F, Ma C, Sun W and Zhang L: Frequent loss of PDCD4 expression in
human glioma: Possible role in the tumorigenesis of glioma. Oncol
Rep. 17:123–128. 2007.PubMed/NCBI
|
|
28
|
Kalinichenko SV, Kopantzev EP, Korobko EV,
Palgova IV, Zavalishina LE, Bateva MV, Petrov AN, Frank GA,
Sverdlov ED and Korobko IV: Pdcd4 protein and mRNA level
alterations do not correlate in human lung tumors. Lung Cancer.
62:173–180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lei Y, Hu X, Li B, Peng M, Tong S, Zu X,
Wang Z, Qi L and Chen M: miR-150 modulates cisplatin
chemosensitivity and invasiveness of muscle-invasive bladder cancer
cells via targeting PDCD4 in vitro. Med Sci Monit. 20:1850–1857.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Torres A, Torres K, Paszkowski T, Radej S,
Staśkiewicz GJ, Ceccaroni M, Pesci A and Maciejewski R: Highly
increased maspin expression corresponds with up-regulation of
miR-21 in endometrial cancer: A preliminary report. Int J Gynecol
Cancer. 21:8–14. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen YZ, Wang JH, Yan J, Liang Y, Zhang XF
and Zhou F: Increased expression of the adult stem cell marker
Musashi-1 in the ectopic endometrium of adenomyosis does not
correlate with serum estradiol and progesterone levels. Eur J
Obstet Gynecol Reprod Biol. 173:88–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maia H Jr, Maltez A, Studard E, Zausner B,
Athayde C and Coutinho E: Effect of the menstrual cycle and oral
contraceptives on cyclooxygenase-2 expression in the endometrium.
Gynecol Endocrinol. 21:57–61. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bulun SE, Zeitoun KM, Takayama K and
Sasano H: Molecular basis for treating endometriosis with aromatase
inhibitors. Hum Reprod Update. 6:413–418. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang X, Wei Z, Gao F, Zhang X, Zhou C, Zhu
F, Wang Q, Gao Q, Ma C, Sun W, et al: Expression and prognostic
significance of PDCD4 in human epithelial ovarian carcinoma.
Anticancer Res. 28:2991–2996. 2008.PubMed/NCBI
|
|
35
|
Ma G, Zhang H, Dong M, Zheng X, Ozaki I,
Matsuhashi S and Guo K: Downregulation of programmed cell death 4
(PDCD4) in tumorigenesis and progression of human digestive tract
cancers. Tumour Biol. 34:3879–3885. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang S, Li J, Jiang Y, Xu Y and Qin C:
Programmed cell death 4 (PDCD4) suppresses metastastic potential of
human hepatocellular carcinoma cells. J Exp Clin Cancer Res.
28:712009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Böhm M, Sawicka K, Siebrasse JP,
Brehmer-Fastnacht A, Peters R and Klempnauer KH: The transformation
suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and
binds RNA. Oncogene. 22:4905–4910. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Palamarchuk A, Efanov A, Maximov V,
Aqeilan RI, Croce CM and Pekarsky Y: Akt phosphorylates and
regulates Pdcd4 tumor suppressor protein. Cancer Res.
65:11282–11286. 2005. View Article : Google Scholar : PubMed/NCBI
|
